Streetbeat News

Earnings

TARS

Tarsus Pharmaceuticals (NASDAQ:TARS) reported Q4 earnings with losses of $(1.31) per share, surpassing the $(1.36) estimate. Sales reached $13.08M, exceeding the $5.66M forecast. This marks a significant improvement over the previous year's performance.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 5:27 pm

HIMS

Hims & Hers Health, Inc. (NYSE:HIMS) shares surged after reporting Q4 earnings of 1 cent per share, surpassing the expected loss of 3 cents, and revenue growth of 47.5% year over year to $246.62 million. The company also provided strong guidance for Q1 2024 and FY 2024, exceeding analyst estimates. Truist Securities and Piper Sandler adjusted their price targets upwards, reflecting a positive outlook.

Portfolio Pulse from Erica Kollmann

February 27, 2024 | 5:27 pm

HSII

Heidrick & Struggles' shares surged following the announcement of Q4 financial results that exceeded expectations and the issuance of Q1 consolidated net revenue guidance that surpassed estimates.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 5:25 pm

HIMS

JANX

NERV

NRXP

TWKS

VKTX

Macy's Inc announced mixed Q4 results and plans to close 150 stores as part of a new growth strategy. U.S. stocks traded mixed, with the Dow Jones falling and NASDAQ rising. Janux Therapeutics, Hims & Hers Health, and Viking Therapeutics saw significant stock increases, while Minerva Neurosciences, Thoughtworks Holding, and NRx Pharmaceuticals experienced declines. Oil prices rose by 1%, and gold increased slightly.

Portfolio Pulse from Avi Kapoor

February 27, 2024 | 5:24 pm

AHCO

AdaptHealth's stock price increased following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 5:18 pm

AJX

Gret Ajax shares are trading lower following the announcement of disappointing Q4 Adjusted EPS results and a decline in Q4 net interest income compared to the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 5:16 pm

PDD

PDD Holdings (NASDAQ:PDD) has seen significant options trading activity, with a bearish sentiment prevailing among investors. Analysis of 61 trades revealed 37% bullish and 62% bearish positions, with puts totaling $2,344,312 and calls at $2,767,412. The options market predicts a price range of $100.0 to $185.0 for PDD Holdings. The largest trades include both bullish and bearish positions with varying strike prices and expiration dates. PDD Holdings, a multinational commerce group, has seen its stock price increase by 1.04% to $127.8, with a high trading volume and an RSI indicating potential overbought status. The next earnings report is due in 20 days.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:15 pm

LGND

Ligand Pharmaceuticals' shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided positive guidance for the future.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 5:12 pm

HERTF

Heritage Cannabis Holdings Corp. (OTCQB:HERTF) reported a significant increase in gross margin for 2023, with over 50% for the year and 628% for Q4 compared to last year. CEO David Schwede attributed this success to product optimization, production efficiencies, and high gross margin sales. The company's products, including RAD vape and Adults Only brand, remain in high demand, particularly in New York, Missouri, and West Virginia. Despite a slight drop in net revenue for Q4 2023, the company saw a decrease in comprehensive loss and general and administrative expenses, indicating improved financial health.

Portfolio Pulse from Jelena Martinovic

February 27, 2024 | 5:10 pm

NLR

URA

URNM

UUUU

Energy Fuels (AMEX:UUUU) plans to open two uranium mines in Colorado and Wyoming, potentially doubling its uranium output to over two million pounds annually by 2025. The company reported a net income of nearly $100 million in 2023 and contracted sales of 100,000 pounds at $102.88 per pound in Q1 2024. Energy Fuels is also focusing on exploration and permitting for future production. Additionally, three ETFs, Global X Uranium ETF (NYSE:URA), North Shore Global Uranium Mining ETF (NYSE:URNM), and VanEck Vectors Uranium+Nuclear Energy ETF (NYSE:NLR), offer investment opportunities in the uranium sector.

Portfolio Pulse from Stjepan Kalinic

February 27, 2024 | 5:10 pm